UCB Pharma S.A.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Belgium
- Registered address
- Chemin du Foriest, Braine-l'Alleud, 1420, Belgium (BEL)
- Operations here
- analysisapi manufacturelabelmanufacturepackrelabelrepack
- FDA identifiers
- FEI 3003909356 · DUNS 400112724
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-02-01
- VAIDrug Quality Assurance2021-11-25
- VAIDrug Quality Assurance2017-01-27
- NAIDrug Quality Assurance2015-09-11
- VAIDrug Quality Assurance2014-12-16
- NAIDrug Quality Assurance2013-02-01
- NAIDrug Quality Assurance2011-07-01
Drugs this plant is listed as making
1 distinct drugs across 3 products name this site in their FDA label.
- certolizumab pegolUCB, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.